CD274 and non-small cell lung carcinoma: This evaluation includes 1,020 patients from 14 randomized controlled clinical studies to evaluate the clinical effectiveness and safety of nourishing yin and replenishing qi traditional Chinese medicine (TCM) with PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer.